{"id":37639,"title":"The impact of delayed treatment on progression of uncomplicated P. falciparum malaria to severe malaria: a pooled multicentre individual-patient meta-analysis.","title_html":"<p>The impact of delayed treatment on progression of uncomplicated <em>P. falciparum<\/em> malaria to severe malaria: a pooled multicentre individual-patient meta-analysis.<\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.bgzfjx3n","doi_status":2,"uri":"the-impact-of-delayed-treatment-on-progression-of-bgzfjx3n","type_id":1,"template_id":1,"published_on":1603209963,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"version_data":{"id":"0","code":"bgzfjx3n","parent_id":0,"parent_uri":null,"is_same_owner":false,"has_pending_merge_request":false,"has_approved_merge_request":false},"created_on":1590911849,"modified_on":null,"categories":null,"public":1,"is_unlisted":0,"creator":{"name":"Andria Mousa","affiliation":null,"affiliations":[],"username":"m4tle112z1z4ule1","note":null,"link":"https:\/\/doi.org\/10.1371\/journal.pmed.1003359","image":{"source":"\/img\/avatars\/010.png","placeholder":"\/img\/avatars\/010.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":"PLOS Medicine","journal_name":"PLOS Medicine","journal_link":"https:\/\/doi.org\/10.1371\/journal.pmed.1003359","article_citation":"Mousa A,  Al-Taiar A,  Anstey NM,  Badaut C,  Barber BE,  Bassat Q,  Challenger JD,  Cunnington AJ,  Datta D,  Drakeley C,  Ghani AC,  Gordeuk VR,  Grigg MJ,  Hugo P,  John CC,  Mayor A,  Migot-Nabias F,  Opoka RO,  Pasvol G,  Rees C,  Reyburn H,  Riley EM,  Shah BN,  Sitoe A,  Sutherland CJ,  Thuma PE,  Unger SA,  Viwami F,  Walther M,  Whitty CJM,  William T,  Okell LC (2020) The impact of delayed treatment of uncomplicated <i>P<\/i>. <i>falciparum<\/i> malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis. PLoS Med  17(10): e1003359. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pmed.1003359\">10.1371\/journal.pmed.1003359<\/a> ","has_versions":0,"link":"https:\/\/doi.org\/10.1371\/journal.pmed.1003359","total_collections":0,"number_of_steps":8,"authors":[{"name":"Andria Mousa","affiliation":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK","affiliations":[],"username":"m4tle112z1z4ule1","note":null,"link":null,"image":{"source":"\/img\/avatars\/010.png","placeholder":"\/img\/avatars\/010.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Dr Joseph Challenger","affiliation":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK","affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Dr Lucy Okell","affiliation":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK","affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/the-impact-of-delayed-treatment-on-progression-of-bgzfjx3n","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"722D29D0A31311EAB09F319F1EC7EDC5","state_version_id":219,"steps":[{"id":952490,"guid":"5EDBFBD0A31411EAB09F319F1EC7EDC5","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"B39958A37D344528B708DD4B1D839842","order_id":1,"type_id":6,"title":"Section","source":{"title":"Research Question, study design and conditions being studied"}},{"id":1054724,"guid":"8F1037C1D2FA4A9F8924A61AF57D3667","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Research Question:<\/span><span style = \"font-style:italic;font-weight:bold;\"> <\/span><\/div><div class = \"text-block\"><span>What is the impact of improved access to treatment in reducing progression from uncomplicated <\/span><span style = \"font-style:italic;\">P. falciparum <\/span><span>malaria to severe disease?<\/span><\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Study design:<\/span><span style = \"font-style:italic;font-weight:bold;\"> <\/span><\/div><div class = \"text-block\"><span>An individual-participant meta-analysis of observational studies of hospital admission of severe and uncomplicated <\/span><span style = \"font-style:italic;\">Plasmodium falciparum <\/span><span>malaria cases. <\/span><\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Conditions or domains being studied<\/span><span style = \"font-style:italic;font-weight:bold;\">:<\/span><\/div><div class = \"text-block\"><span>Severe malaria (TMIH WHO 2014 criteria[1]): Diagnosis of <\/span><span style = \"font-style:italic;\">Plasmodium falciparum<\/span><span> infection and at least one of the following symptoms or severe disease types diagnosed, in the absence of an alternative cause:<\/span><\/div><div class = \"text-block\">-Cerebral malaria<\/div><div class = \"text-block\">-Severe malarial anaemia<\/div><div class = \"text-block\">-Hyperlactatemia<\/div><div class = \"text-block\">-Acidosis<\/div><div class = \"text-block\">-Respiratory distress<\/div><div class = \"text-block\">-Hypoglycaemia<\/div><div class = \"text-block\">-Renal failure<\/div><div class = \"text-block\">-Hyperparasitaemia<\/div><div class = \"text-block\">-Jaundice<\/div><div class = \"text-block\">Uncomplicated malaria (comparator group): presence of Plasmodium falciparum infection at the time of admission, diagnosed by either RDT, microscopy or PCR and absence of severe symptoms. <\/div><div class = \"text-block\">Delay to treatment from symptom onset (measure of exposure) will be compared between uncomplicated cases and severe malaria cases, as well as between different types of severe malaria.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":956896,"guid":"4551CF90A98711EA8C6D3135BB0B6EF1","previous_id":952490,"previous_guid":"5EDBFBD0A31411EAB09F319F1EC7EDC5","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"90F0746BBD024E73B73E9ED52AF2ED39","order_id":1,"type_id":6,"title":"Section","source":{"title":"Search dates, sources and strategy"}},{"id":1054724,"guid":"3931BF80AF594EAAAFB33299B6C661A7","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Time span:<\/span><\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\"> <\/span><span>Inceptions<\/span><span style = \"font-style:italic;\"> to<\/span><span> 22\/11\/2017<\/span><\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Sources searched:<\/span><\/div><div class = \"text-block\">Ovid MEDLINE, Embase<\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Restrictions<\/span><span style = \"font-style:italic;font-weight:bold;\">:<\/span><span style = \"font-weight:bold;\"> <\/span><\/div><div class = \"text-block\">No restrictions on language or year of publication<\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Search strategy<\/span><span style = \"font-weight:bold;\">: <\/span><\/div><div class = \"text-block\">(malaria* or falciparum) AND (severe or cerebral) AND ((duration adj3 (illness or disease)) or delay* or access* or distance or travel* or case-control or risk factor or risk factors))<\/div><div class = \"text-block\">All terms searched in all fields.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":956898,"guid":"670AEDB0A98711EA8C6D3135BB0B6EF1","previous_id":956896,"previous_guid":"4551CF90A98711EA8C6D3135BB0B6EF1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"8FF22F6ADB8C4A5BAFC4C9CADC3B594B","order_id":1,"type_id":6,"title":"Section","source":{"title":"Screening process and inclusion\/ exclusion criteria"}},{"id":1054724,"guid":"96ECEC0417A94433BDEE247A372B5734","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">One reviewer will conduct study selection. Study selection decisions, and extraction will be checked by a second reviewer. EndNote X8 will be used for screening.<\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Inclusion criteria:<\/span><\/div><div class = \"text-block\"><ul style = \"list-style-type:disc;\"><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies containing data on severe disease<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies with available data on delay to treatment defined as duration of symptoms or fever prior to admission.<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies published in any language<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies published in any year<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies that contain data on patients infected with P. falciparum<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies of participants of any age group<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\"><\/li><li style = \"counter-reset:ol0;list-style-type:disc;\"><span style = \"font-style:italic;font-weight:bold;\">Exclusion criteria:<\/span><\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies which collected data on only uncomplicated malaria<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Case reports<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies with small total sample sizes (<100)<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies in non-endemic settings <\/li><\/ul><\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Exclusion criteria:<\/span><\/div><div class = \"text-block\"><ul style = \"list-style-type:disc;\"><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies which collected data on only uncomplicated malaria<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Case reports<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies with small total sample sizes (<100)<\/li><li style = \"counter-reset:ol0;list-style-type:disc;\">Studies in non-endemic settings <\/li><\/ul><\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Types of study to be included<\/span><span style = \"font-weight:bold;\">: <\/span><\/div><div class = \"text-block\">Studies to be included are mainly case-control studies of severe vs. uncomplicated malaria. Large studies of severe disease which did not have a case-control design (e.g. cohort studies) were still considered if they were sufficiently large (n>100) and contained relevant data to allow comparisons of different types of severe malarial disease.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#84CE84","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":956900,"guid":"D90712E0A98711EA8C6D3135BB0B6EF1","previous_id":956898,"previous_guid":"670AEDB0A98711EA8C6D3135BB0B6EF1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"7972D697AE454FE89516056D96AFEBD4","order_id":1,"type_id":6,"title":"Section","source":{"title":"Exposure and outcomes"}},{"id":1054724,"guid":"88FE74BC86C944129684774B0EBB87E2","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Exposure:<\/span><\/div><div class = \"text-block\">The primary exposure being studied is delay to treatment, quantified as self-reported duration of illness or fever prior to being admitted to a health facility.<\/div><div class = \"text-block\">Secondary exposures being studied include travelling time and distance to the health facility, as well as receiving treatment prior to arriving at the health facility.<\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Main outcome:<\/span><\/div><div class = \"text-block\">The main outcome is the change in odds of severe malarial disease, overall and stratified by type of severe malarial disease. Severe malaria status is determined at the time of admission.<\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Additional outcomes:<\/span><\/div><div class = \"text-block\">Short-term mortality, need for transfusion and haemoglobin levels are secondary outcomes, provided there is available data. The odds of death and odds of increased haemoglobin will be compared between different levels of delay. Haemoglobin levels are measured at the time of admission. Mortality is defined as death during hospital stay.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":956903,"guid":"03260090A98811EA8C6D3135BB0B6EF1","previous_id":956900,"previous_guid":"D90712E0A98711EA8C6D3135BB0B6EF1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"D319436924BA421EB7BD49A39250CA41","order_id":1,"type_id":6,"title":"Section","source":{"title":"Step 5: Data extraction and quality assessment"}},{"id":1054724,"guid":"40ED6B313C57492D870ED00232CC6223","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Data extraction:<\/span><\/div><div class = \"text-block\">Data extracted initially will be the following: author names and contact details, country and transmission setting, ages, study design and matching, sample size, symptoms, inclusion and exclusion criteria, mean effect of delay (if measured), mortality, travel time and distance to the health facility, treatment (type) prior to admission, education of mother, definitions for severe and uncomplicated malaria. <\/div><div class = \"text-block\">All authors will be contacted for individual-level data as some studies may not estimate the association between delay and progression, despite having collected data on duration of illness. Missing data will also be requested.<\/div><div class = \"text-block\">Microsoft Excel and Stata 14 will be used for data storage and management.<\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Risk of bias (quality) assessment:<\/span><\/div><div class = \"text-block\">A quality assessment will be carried out by two reviewers using the Newcastle Ottawa risk of bias tool for non-randomised studies. Studies will also be scored separately on the number of confounders they measure, including age, travelling time\/distance, and mother's education.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#EA9F6C","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":956904,"guid":"31BCBAC0A98811EA8C6D3135BB0B6EF1","previous_id":956903,"previous_guid":"03260090A98811EA8C6D3135BB0B6EF1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"181D936968054C00BC2C265A729F36AF","order_id":1,"type_id":6,"title":"Section","source":{"title":"Strategy for data synthesis"}},{"id":1054724,"guid":"A9787897C1444A9AAD5307636A10147C","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Pooled analysis: Age-adjusted, mixed-effects multivariable logistic regressions will be used to account for random effects among studies and this will be done separately for children and adults aged 15 or over. ORs and 95% confidence intervals quantifying the risk of progression to severe malarial disease, specific types of severe malarial disease or mortality, will be estimated for different categories of delay prior to seeking treatment. Confounders such as age, travelling time, distance, mother's education and transmission intensity will be investigated in subgroup analyses to determine their impact on the association between delay to treatment and progression to severe malarial disease. Data will be analysed using Stata 14.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#E57785","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":956905,"guid":"781A5720A98811EA8C6D3135BB0B6EF1","previous_id":956904,"previous_guid":"31BCBAC0A98811EA8C6D3135BB0B6EF1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"723777B50B954D6ABFC01C53092A0200","order_id":1,"type_id":6,"title":"Section","source":{"title":"Analysis of subgroups or subsets"}},{"id":1054724,"guid":"32B9512B4A744F5093C6868A34090486","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">The main analysis (mixed-effects logistic regression of IPD) will be stratified by children (<15 years) and adults (15+ years). To explore the effects of confounders, the main analysis will be adjusted for age, distance or travelling time to the health facility, treatment prior to admission to the health facility, transmission intensity of the setting and other potential factors such mother's education. The presence of effect modification of these variables will be investigated by fitting an interaction between the effect of delay and the above factors, e.g. transmission intensity category or age.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#EA94FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":956906,"guid":"8C4ACC20A98811EA8C6D3135BB0B6EF1","previous_id":956905,"previous_guid":"781A5720A98811EA8C6D3135BB0B6EF1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"71598D6AC8AF4298A69561C12CABE5CB","order_id":1,"type_id":6,"title":"Section","source":{"title":"References"}},{"id":1054724,"guid":"3F324C6C52E84859B75BC3798292DD3F","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">1.World Health Organization. Severe Malaria. Tropical Medicine & International Health. 2014;19(s1):7-131. doi: doi:10.1111\/tmi.12313_2.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0}],"document":null,"materials":[],"description":null,"changed_on":1603209963}